Brusaferro, 11 cases of Omicron, the incidence still increasing, the epidemic is expanding

'Currently in Italy there are

, others are suspect, and affect more' regions', namely

. 'They concern cases of people who

'. In general, the epidemic is expanding, with Rt at 1.2 and an incidence increasing to 173 cases per 100,000 people between 29 November and 6 December and a "strong match" between the spread and the unvaccinated population. This was explained by the president of the Istituto Superiore di Sanità (Iss), Silvio Brusaferro, in a hearing in the Senate Constitutional Affairs Commission on "Vaccination obligations and strengthening of green Covid-19 certifications".

NON-VACCINATED -

"The population over 12 still sees

, many are of working age between 30 and 60 years, he stresses.

ADMISSIONS -

"As far as bed occupancy is concerned - continues Brusaferro - we have a growth that increases by about one percentage point per week at the national level" and "continues to grow even in intensive care".

As well as "an Rt around 1.2 - tonight or tomorrow we will have more updated data but the preliminary ones show that we are sticking to this trend - indicates that we are still in a situation of growth in circulation".

THE INCIDENCE -

"We are still - he remarks - in an epidemic situation. The data updated last night show that it is still increasing in terms of the number of new infected, with an incidence of 173 cases per 100,000 people" between 29 November and December 6. And it is "a trend in circulation that affects some groups more than others, showing a strong correspondence with the unvaccinated population", declared the president of the Istituto Superiore di Sanità (Iss), Silvio Brusaferro, during a hearing in the Business Commission Constitutional Senate on "Vaccination obligations and strengthening Covid-19 green certifications". "The population over 12 still sees 6 million and 570 thousand people who have not started any vaccination cycle, many are of working age between 30 and 60 years.

THE THIRD DOSES -

Excluding children under 30, the lowest coverage is in the 30-49 age group, which is also the one characterized by the greatest circulation.

The positive fact is that the administration of the third dose is increasing significantly in the ultra-80s.

We have reached 57% based on last night's data ", is a small message of hope from the president of the Istituto Superiore di Sanità (Iss).